Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Akassoglou

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Glia|October 12, 2001
Glial expression of tumor necrosis factor in transgenic animals: how do these models reflect the "normal situation"?L Probert, K Akassoglou
Biochemical Society Transactions|October 25, 2007
Regulation of cAMP by the p75 neurotrophin receptor: insight into drug design of selective phosphodiesterase inhibitorsB D Sachs, K Akassoglou
Journal of Thrombosis and Haemostasis : JTH|July 28, 2009
Fibrinogen signal transduction in the nervous systemJ K Ryu, D Davalos, K Akassoglou
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1997
Astrocyte-specific but not neuron-specific transmembrane TNF triggers inflammation and degeneration in the central nervous system of transgenic miceK Akassoglou, L Probert, G Kontogeorgos, et al.
The Journal of Prevention of Alzheimer'S Disease|October 24, 2023
Fibrin-Targeting Immunotherapy for DementiaA B Kantor, K Akassoglou, J B Stavenhagen
The Journal of Cell Biology|June 1, 2000
Tissue plasminogen activator-mediated fibrinolysis protects against axonal degeneration and demyelination after sciatic nerve injuryK Akassoglou, K W Kombrinck, J L Degen, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 21, 1995
Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alphaL Probert, K Akassoglou, M Pasparakis, et al.
Current Medicinal Chemistry|November 30, 2007
Fibrinogen signal transduction as a mediator and therapeutic target in inflammation: lessons from multiple sclerosisR A Adams, C Schachtrup, D Davalos, et al.
European Journal of Immunology|March 26, 1999
A tumor necrosis factor-induced model of human primary demyelinating diseases develops in immunodeficient miceG Kassiotis, J Bauer, K Akassoglou, et al.
Journal of Neuroimmunology|February 1, 1997
TNF-alpha transgenic and knockout models of CNS inflammation and degenerationL Probert, K Akassoglou, G Kassiotis, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Glia|October 12, 2001
Glial expression of tumor necrosis factor in transgenic animals: how do these models reflect the "normal situation"?L Probert, K Akassoglou
Biochemical Society Transactions|October 25, 2007
Regulation of cAMP by the p75 neurotrophin receptor: insight into drug design of selective phosphodiesterase inhibitorsB D Sachs, K Akassoglou
Journal of Thrombosis and Haemostasis : JTH|July 28, 2009
Fibrinogen signal transduction in the nervous systemJ K Ryu, D Davalos, K Akassoglou
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1997
Astrocyte-specific but not neuron-specific transmembrane TNF triggers inflammation and degeneration in the central nervous system of transgenic miceK Akassoglou, L Probert, G Kontogeorgos, et al.
The Journal of Prevention of Alzheimer'S Disease|October 24, 2023
Fibrin-Targeting Immunotherapy for DementiaA B Kantor, K Akassoglou, J B Stavenhagen
The Journal of Cell Biology|June 1, 2000
Tissue plasminogen activator-mediated fibrinolysis protects against axonal degeneration and demyelination after sciatic nerve injuryK Akassoglou, K W Kombrinck, J L Degen, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 21, 1995
Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alphaL Probert, K Akassoglou, M Pasparakis, et al.
Current Medicinal Chemistry|November 30, 2007
Fibrinogen signal transduction as a mediator and therapeutic target in inflammation: lessons from multiple sclerosisR A Adams, C Schachtrup, D Davalos, et al.
European Journal of Immunology|March 26, 1999
A tumor necrosis factor-induced model of human primary demyelinating diseases develops in immunodeficient miceG Kassiotis, J Bauer, K Akassoglou, et al.
Journal of Neuroimmunology|February 1, 1997
TNF-alpha transgenic and knockout models of CNS inflammation and degenerationL Probert, K Akassoglou, G Kassiotis, et al.
Pageof 2